OCC 1.23% 40.0¢ orthocell limited

30% growth sound pretty good but they are hardly off large...

  1. 742 Posts.
    lightbulb Created with Sketch. 206
    30% growth sound pretty good but they are hardly off large revenues. I think the up front deal for Striate was a good move and to sure up funds a positive. IMO they need to get more market share with Striate but more so get the USA approvals for remplir. Hopefully a new deal might be less up front and better retained revenues. Still some time to play before a significant re-rate so I’ll be waiting to top up.
 
watchlist Created with Sketch. Add OCC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.